Your browser doesn't support javascript.
loading
Evaluation of serum tumor markers usage in Syrian cancer patients
Arab Journal of Pharmaceutical Sciences. 2005; 3 (1): 85-92
in Arabic | IMEMR | ID: emr-69882
ABSTRACT
The study was conducted on 106 patients suffering from different cancer types. 59 males aging 5-70 and 47 females aging 3-65 The patients were referred from specialists to the oncology clinics. They were tested for the following tumor markers CA19-9, CA15-3, PSA, and CA-125. according to their cancer type. Results from pathologic anatomy were used in the diagnosis and follow-up Lymphomas. This study revealed that the most common types of cancer is Lymphomas including its two types [Hodgkin's disease and Non-Hodgkin's lymphoma NHL], The percentage of male cancer patients was 55.6% whereas in females were 44.4%. A follow-up of some of the patients was performed using tumor markers, ALP and LDH in order to monitor their serologic levels during treatment, which it was surgical or therapeutic management
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Biomarkers, Tumor / Follow-Up Studies / Prostate-Specific Antigen / CA-19-9 Antigen / Mucin-1 / CA-125 Antigen / Lymphoma / Neoplasms Limits: Female / Humans / Male Language: Arabic Journal: Arab J. Pharm. Sci. Year: 2005

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Biomarkers, Tumor / Follow-Up Studies / Prostate-Specific Antigen / CA-19-9 Antigen / Mucin-1 / CA-125 Antigen / Lymphoma / Neoplasms Limits: Female / Humans / Male Language: Arabic Journal: Arab J. Pharm. Sci. Year: 2005